Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS30058043HIVENSG00000114573.12protein_codingATP6V1ANoNo523P38606
TVIS30058044HIVENSG00000114573.12protein_codingATP6V1ANoNo523P38606
TVIS30058045HIVENSG00000114573.12protein_codingATP6V1ANoNo523P38606
TVIS30058046HIVENSG00000114573.12protein_codingATP6V1ANoNo523P38606
TVIS20036688HPVENSG00000114573.12protein_codingATP6V1ANoNo523P38606
TVIS20056814HPVENSG00000114573.12protein_codingATP6V1ANoNo523P38606
TVIS44006999HTLV-1ENSG00000114573.12protein_codingATP6V1ANoNo523P38606
TVIS44044740HTLV-1ENSG00000114573.12protein_codingATP6V1ANoNo523P38606
TCGA Plot Options
Drug Information
GeneATP6V1A
DrugBank IDDB00630
Drug NameAlendronic acid
Target IDBE0003569
UniProt IDP38606
Regulation Typeinhibitor
PubMed IDs8889850
CitationsDavid P, Nguyen H, Barbier A, Baron R: The bisphosphonate tiludronate is a potent inhibitor of the osteoclast vacuolar H(+)-ATPase. J Bone Miner Res. 1996 Oct;11(10):1498-507.
GroupsApproved
Direct ClassificationBisphosphonates
SMILESNCCCC(O)(P(O)(O)=O)P(O)(O)=O
PathwaysAlendronate Action Pathway
PharmGKBPA448082
ChEMBLCHEMBL870